Ciloxan for the management of corneal ulcers.
Bacterial keratitis (corneal ulcer) is a sight-threatening condition if not treated with the appropriate anti-infective agent. Treatment needs to be initiated with a broad-spectrum agent deemed to be most appropriate until culture results are obtained. If the suspected pathogen is staphylococci, streptococci, or Pseudomonas, Ciloxin is a new generation anti-infective agent considered highly effective against these pathogens.